Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva Poveda

Showing results (11-20 of 149) with videos related to

Pageof 15
Sort By:
AIDS Reviews|February 10, 2017
Similar Immunological Profiles Between Nonprogressing HIV Infection in Children and Nonpathogenic SIV InfectionEva Poveda, Enrique Martin-Gayo
Enfermedades Infecciosas Y Microbiologia Clinica|January 10, 2009
[Methods for determining viral tropism: genotype and phenotype tests]Mayte Perez-Olmeda, Eva Poveda
AIDS Reviews|October 12, 2017
Exosomes as New Players in HIV Pathogenesis - New Data from the IAS 2017Eva Poveda, Michael L Freeman
Medicina Clinica|May 3, 2006
[HIV entry into the cells--mechanisms and therapeutic possibilities]Verónica Briz, Eva Poveda, Vicente Soriano
The Journal of Antimicrobial Chemotherapy|February 9, 2006
HIV entry inhibitors: mechanisms of action and resistance pathwaysVerónica Briz, Eva Poveda, Vincent Soriano
Journal of Clinical Microbiology|November 1, 2002
Rapid assessment of phenotypic resistance to protease inhibitors in human immunodeficiency virus type 1 group OBerta Rodés, Eva Poveda, Vincent Soriano
AIDS Reviews|November 24, 2005
Enfuvirtide, the first fusion inhibitor to treat HIV infectionEva Poveda, Verónica Briz, Vincent Soriano
Clinics in Liver Disease|August 3, 2013
Hepatitis B in HIV-infected patientsVincent Soriano, Eva Poveda, Eugenia Vispo, et al.
Transplantation|January 25, 2003
Rapid development of subacute myelopathy in three organ transplant recipients after transmission of human T-cell lymphotropic virus type I from a single donorCarlos Toro, Berta Rodés, Eva Poveda, et al.
AIDS Research and Human Retroviruses|May 1, 2004
Are fusion inhibitors active against all HIV variants?Eva Poveda, Berta Rodes, Carlos Toro, et al.
Pageof 15

Showing results (11-20 of 149) with videos related to

Sort By:
Pageof 15
AIDS Reviews|February 10, 2017
Similar Immunological Profiles Between Nonprogressing HIV Infection in Children and Nonpathogenic SIV InfectionEva Poveda, Enrique Martin-Gayo
Enfermedades Infecciosas Y Microbiologia Clinica|January 10, 2009
[Methods for determining viral tropism: genotype and phenotype tests]Mayte Perez-Olmeda, Eva Poveda
AIDS Reviews|October 12, 2017
Exosomes as New Players in HIV Pathogenesis - New Data from the IAS 2017Eva Poveda, Michael L Freeman
Medicina Clinica|May 3, 2006
[HIV entry into the cells--mechanisms and therapeutic possibilities]Verónica Briz, Eva Poveda, Vicente Soriano
The Journal of Antimicrobial Chemotherapy|February 9, 2006
HIV entry inhibitors: mechanisms of action and resistance pathwaysVerónica Briz, Eva Poveda, Vincent Soriano
Journal of Clinical Microbiology|November 1, 2002
Rapid assessment of phenotypic resistance to protease inhibitors in human immunodeficiency virus type 1 group OBerta Rodés, Eva Poveda, Vincent Soriano
AIDS Reviews|November 24, 2005
Enfuvirtide, the first fusion inhibitor to treat HIV infectionEva Poveda, Verónica Briz, Vincent Soriano
Clinics in Liver Disease|August 3, 2013
Hepatitis B in HIV-infected patientsVincent Soriano, Eva Poveda, Eugenia Vispo, et al.
Transplantation|January 25, 2003
Rapid development of subacute myelopathy in three organ transplant recipients after transmission of human T-cell lymphotropic virus type I from a single donorCarlos Toro, Berta Rodés, Eva Poveda, et al.
AIDS Research and Human Retroviruses|May 1, 2004
Are fusion inhibitors active against all HIV variants?Eva Poveda, Berta Rodes, Carlos Toro, et al.
Pageof 15